Figures
Abstract
Skin changes are seen in up to 20% of patients with COVID-19 and vary widely in presentation. The most common include maculopapular eruptions, ‘COVID toes’, urticaria and most concerningly vaso-occlusive rashes, such as livedo reticularis and retiform purpura. Some of these skin signs are indicators of disease progression or severity.
Key Points
- Skin changes are common in patients with COVID-19, seen in up to 20% of patients.
- Maculopapular eruptions and acral chilblain-like lesions are the most common skin changes seen in patients with COVID-19.
- Many skin changes have prognostic value and associations with severity of disease.
- Most skin changes do not need any specific treatment and resolve spontaneously over time.
